Business-News-Today.com

This account is now @BNTBriefing, covering business, markets, energy, pharma, biotech, medical devices, geopolitics and industry analysis from Business-News-Today.com and PharmaDeviceNews.com. Follow for #executivenews, #marketcatalysts and #sectorintelligence.

Oxford Nanopore (LSE: ONT) retains 2026 guidance despite weaker first-half trading business-news-today.com/oxford-nanopor… $ONT #OxfordNanopore #NanoporeSequencing #Genomics #LifeSciences #BioPharma #PromethION #LSE #FTSE250 #UKStocks #ONT

GSTechnologies (LSE: GST) shares rise 25% in a month as $5m funding resets the story business-news-today.com/gstechnologies… $GST #GSTechnologies #LSE #Fintech #MicroCap #Payments #Crypto #MiCA #UKStocks #RetailInvestors #GST

Medicaroid wins European CE mark for Hinotori surgical robot pharmadevicenews.com/medicaroid-win… #Medicaroid #Hinotori #KawasakiHeavyIndustries #Sysmex #SurgicalRobotics #MedicalDevices #MedTech #Europe #EUMDR

HCLTech Q1 FY27 profit rises 20% as record bookings sharpen the growth test business-news-today.com/hcltech-q1-fy2… #HCLTECH #HCLTech #EnterpriseAI #ITServices #NSE #BSE #SarvamAI #HCLSoftware #IndianStocks

Brave Bison (AIM: BBSN) proposes £43.1 m offer for System1 Group (AIM: SYS1) business-news-today.com/brave-bison-ai… $BBSN $SYS1 #BraveBison #System1Group #MarketingTechnology #AdvertisingTechnology #AIM #TakeoverCode #MergersAndAcquisitions #UKStocks

Chevron locks in Western Australian gas sales from July 2027 under Alinta deal business-news-today.com/chevron-locks-… $CVX #Chevron #AlintaEnergy #NaturalGas #WesternAustralia #Gorgon #Wheatstone #EnergySecurity #LNG

PageGroup (LSE: PAGE) Q2 gross profit beats forecast as Americas and Asia drive recovery business-news-today.com/pagegroup-lse-… $PAGE #PageGroup #RecruitmentIndustry #ExecutiveSearch #WorkforceTechnology #LSE #PageExecutive #MichaelPage #UKStocks

Volkswagen (VOW3) Q2 deliveries fall 8.6% as China plunges 36.6% amid restructuring business-news-today.com/volkswagen-vow… $VOW3 #VOW3 #Volkswagen #VW #Automotive #EVstocks #China #EuropeanStocks #Xetra #Restructuring #AutoStocks

ADNOC L&S (ADX: ADNOCLS) is spending $225m per ship. Will 2029 charters justify the price? business-news-today.com/adnoc-ls-adx-a… $ADNOCLS #ADNOCLogistics #LNGShipping #LNGCarriers #MaritimeLogistics #ADX #JiangnanShipyard #ADNOCGas #UAEStocks #ADNOCLS

Wizz Air is filling planes, so why is LSE: WIZZ under pressure? business-news-today.com/wizz-air-is-fi… $WIZZ #WizzAir #EuropeanAirlines #BudgetAirlines #Aviation #LSE #FTSE250 #Spain #AirbusA321neo #UKStocks

Saipem and Subsea7 merger faces likely EU antitrust probe as July 22 deadline nears business-news-today.com/saipem-and-sub… $SPM $SUBC #Saipem #Subsea7 #OffshoreEnergy #SubseaEngineering #EuronextMilan #OsloBors #EUCompetition #EuropeanStocks

AVZ Minerals faces a recovery test at Manono (formerly ASX: AVZ) business-news-today.com/avz-minerals-f… #AVZ #AVZMinerals #Manono #Lithium #DRC #ICSID #CriticalMinerals #Mining #Shareholders

Baker Hughes cleared its biggest regulatory hurdle, but the Chart deal comes with strings business-news-today.com/baker-hughes-c… $BKR #BakerHughes $GTLS #ChartIndustries #EuropeanCommission #LNG #EnergyTechnology #NASDAQ #NYSE #USStocks

Island Pharmaceuticals (ASX:ILA) shares rise as Texas Biomed expands Galidesivir regulatory pathway business-news-today.com/island-pharmac… $ILA #IslandPharmaceuticals #Galidesivir #TexasBiomed #MarburgVirus #Biodefence #FDA #USAMRIID #ASX #ASXStocks #ILA

@TakedaPharma $30m Indonesia plasma bet starts with donors, not the drug factory pharmadevicenews.com/takedas-30m-in… Takeda plans a $30 million Indonesia plasma network as local manufacturing stays under review. See what the deal changes for medicine access. #Takeda #Indonesia #BioLife #PlasmaDonation #PlasmaDerivedTherapies #RareDiseases #HealthcareResilience #ASEAN

Could deupirfenidone beat an approved IPF drug? @CeleaTx starts the Phase 3 test that will decide pharmadevicenews.com/could-deupirfe… Celea Therapeutics has begun an unusually ambitious Phase 3 program designed to prove that deupirfenidone is superior, rather than merely comparable, to the established antifibrotic pirfenidone. The approximately 1,100-patient trial could support a United States registration application if successful, but its 2029 readout leaves the company facing a long development period and an increasingly competitive idiopathic pulmonary fibrosis market. #CeleaTherapeutics #Deupirfenidone #SURPASSIPF #IdiopathicPulmonaryFibrosis #IPF #ClinicalTrials #Biotechnology #DrugDevelopment #PureTechHealth #FDA

@iHealthScreen cleared a crucial FDA hurdle, but can iPredict-DR break AI eye screening’s adoption barrier? pharmadevicenews.com/ihealthscreen-… iHealthScreen’s FDA-cleared iPredict-DR brings automated diabetic retinopathy screening closer to primary care, but adoption hurdles remain. #iHealthScreen #iPredictDR #DiabeticRetinopathy #FDA #MedicalDevices #HealthAI #Ophthalmology #DiabetesCare #DigitalHealth

Ionis Pharmaceuticals shares slide as eplontersen misses key heart disease endpoint pharmadevicenews.com/ionis-pharmace… See why the CARDIO-TTRansform miss complicates eplontersen’s ATTR-CM path and tests gene silencing on top of stabilizer therapy. #IonisPharmaceuticals #AstraZeneca #Eplontersen #Wainua #CardioTTRansform #ATTRCM #Cardiomyopathy #ClinicalTrials #Biotech #Pharma @ionispharma Pharmaceuticals @AstraZeneca

@NateraGenetics just cleared a major European hurdle for Signatera, but can hospitals turn certification into adoption? pharmadevicenews.com/natera-just-cl… Natera’s Signatera gains European IVDR certification across multiple cancers, opening a new phase for personalized MRD testing and clinical adoption. #Natera #Signatera #NTRA #IVDR #MolecularDiagnostics #MRD #LiquidBiopsy #Oncology #CancerDiagnostics #PrecisionMedicine

Why @BritishBBank just made its biggest life sciences bet on @alchemabtx pharmadevicenews.com/why-british-bu… Alchemab Therapeutics secures £25 million to double its antibody data and advance two wholly owned programs toward clinical development. #AlchemabTherapeutics #BritishBusinessBank #Resiliome #ATLX1282 #ATLX2847 #EliLilly #ALS #Biotech #AntibodyDiscovery #ArtificialIntelligence